MRNS - Marinus stock jumps 11% on financial pipeline updates
2023-09-19 12:36:23 ET
More on Marinus Pharmaceuticals
- Evaluating Marinus: Ztalmy's Growth And Upcoming Trial Insights
- Marinus: Transforming The Seizure Market With Ganaxolone (Rating Upgrade)
- Marinus downgraded by Oppenheimer on concerns over seizure asset trial
- Marinus gets EU approval for anti-seizure treatment Ztalmy
For further details see:
Marinus stock jumps 11% on financial, pipeline updates